Royalty Pharma to Announce Third-Quarter 2021 Financial Results on November 10, 2021
October 18, 2021 09:00 ET
|
RP Management, LLC
NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter of 2021 financial results on Wednesday, November 10, 2021 before...
Royalty Pharma Declares Fourth-Quarter 2021 Dividend
October 15, 2021 09:00 ET
|
RP Management, LLC
NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2021 of $0.17 per Class A...
Royalty Pharma to Present at Upcoming Investor Conferences
September 03, 2021 09:00 ET
|
RP Management, LLC
NEW YORK, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September: ...
Royalty Pharma Reports Second Quarter 2021 Results
August 11, 2021 07:00 ET
|
RP Management, LLC
Strong growth in net cash provided by operating activities (GAAP) and Adjusted Cash Flow(2)Announced transactions of up to $2.8 billion in 2021, including $2.1 billion* in upfront paymentsIncreased...
Royalty Pharma to Announce Second-Quarter 2021 Financial Results on August 11, 2021
July 19, 2021 09:00 ET
|
RP Management, LLC
NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter of 2021 financial results on Wednesday, August 11, 2021 before...
Royalty Pharma Declares Third-Quarter 2021 Dividend
July 16, 2021 09:00 ET
|
RP Management, LLC
NEW YORK, July 16, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2021 of $0.17 per class A...
Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond
July 15, 2021 16:54 ET
|
RP Management, LLC
Social Bond issuance underscores Royalty Pharma’s strong commitment to ESGSupports United Nations Sustainable Development Goals NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma...
Royalty Pharma to Present at Upcoming Investor Conferences
June 07, 2021 09:00 ET
|
RP Management, LLC
NEW YORK, June 07, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of June: ...
Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
June 02, 2021 07:40 ET
|
RP Management, LLC
Royalty Pharma to provide tailored funding solution to enable MorphoSys’ acquisition of Constellation PharmaceuticalsInvestment is anchored by royalties on Janssen’s TremfyaPartnership also includes...
Royalty Pharma Reports First Quarter 2021 Results
May 11, 2021 07:00 ET
|
RP Management, LLC
Double-digit growth in Net cash provided by operating activities (GAAP) and Adjusted Cash Flow(2)Announced transactions of up to $787 million in 2021, including $582 million in upfront...